Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Progress Multiple Sclerosis”

3 trials

Showing 3 of 3 results

Not applicableLooking for participantsNCT07426991
What this trial is testing

Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis

Who this might be right for
Multiple SclerosisRemitting-Relapsing Multiple SclerosisPrimary Progressive Multiple Sclerosis+3 more
Heinrich-Heine University, Duesseldorf 837
Testing effectiveness (Phase 2)UnknownNCT02149706
What this trial is testing

NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Immune Response BioPharma, Inc. 150
Large-scale testing (Phase 3)UnknownNCT02057159
What this trial is testing

NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis

Who this might be right for
Secondary Progress Multiple SclerosisMultiple Sclerosis
Immune Response BioPharma, Inc. 200

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation